AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

CTD-O 6.25/40 Tablet

Prescription Icon
Prescription Required

Marketer

Ipca Laboratories Ltd

Salt Composition

Olmesartan Medoxomil (40mg) + Chlorthalidone (6.25mg)

Overview CTD-O 6.25/40 Tablet

The dual-action CTD-O 6.25/40 Tablet manages hypertension through a two-drug formulation. Untreated high blood pressure significantly elevates the risk of stroke, heart attack, and kidney disease. This medication can be taken with or without food; dosage is individualized based on your response and health status. Consistent daily timing is recommended. Continue this treatment as directed by your physician. Due to its diuretic component (promoting increased urination), avoid taking it within four hours of bedtime. Regular use, even during symptom-free periods, is crucial for optimal effect. High blood pressure is often asymptomatic, and discontinuation increases cardiovascular event risk. Dizziness is the most frequent side effect; others include fatigue, nausea, diarrhea, headache, and hypotension. Increased urination is the expected diuretic effect, vital for blood pressure control. While rare, other side effects may occur. Consult the patient information leaflet and report persistent or bothersome side effects to your doctor; dose adjustment or alternative medication may be considered. This medication is contraindicated in pregnancy. Consult your physician before use if you have kidney or liver impairment, cardiac issues, or diabetes. Alcohol consumption may exacerbate hypotension and side effects.

Uses of CTD-O 6.25/40 Tablet

Elevated blood pressure

Major Benefits of CTD-O 6.25/40 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. CTD-O 6.25/40 Tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of CTD-O 6.25/40 Tablet:

  • Nausea
  • Taste change
  • Diarrhea
  • Upset stomach
  • Weakness
  • Headache
  • Increased blood uric acid
  • Dizziness
  • Increased blood lipid level
  • Electrolyte imbalance
  • Decreased blood pressure
  • Urinary tract infection
  • Renal dysfunction
  • Sore throat
  • Abnormal liver function tests
  • Increased potassium level in blood

How to use CTD-O 6.25/40 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. CTD-O 6.25/40 Tablets can be ingested with or without food, however, consistent timing is recommended.

How CTD-O 6.25/40 Tablet works:

Each CTD-O 6.25/40 Tablet contains a dual-drug formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of CTD-O 6.25/40 tablets and alcohol may result in pronounced somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of CTD-O 6.25/40 Tablet is contraindicated during pregnancy due to established fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of CTD-O 6.25/40 tablets while breastfeeding is likely inadvisable. Scant available evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking a CTD-O 6.25/40 Tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using CTD-O 6.25/40 Tablets, as dosage modification may be necessary. Physician consultation is advised; in fact, CTD-O 6.25/40 Tablets are not recommended for such individuals.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when taking CTD-O 6.25/40 tablets, as dosage modification may be necessary. Consult your physician for guidance. CTD-O 6.25/40 tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take CTD-O 6.25/40 Tablet :

Should you forget to take your CTD-O 6.25/40 Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About CTD-O 6.25/40 Tablet

LabelValue
Developing Habits No.
Treatment Category Heart

FAQs on CTD-O 6.25/40 Tablet

Expect a noticeable blood pressure reduction within two weeks of beginning CTD-O 6.25/40 Tablet, though optimal effects may take eight weeks. Consult your doctor with any concerns, but do not discontinue use without their advice.
To minimize dizziness, your doctor might recommend taking your initial dose before bed. Subsequent doses of CTD-O 6.25/40 Tablet can be taken at any time of day, but consistency is key—take it at the same time daily. If uncertain, consult your doctor.
Dizziness is a possible side effect of CTD-O 6.25/40 Tablet, particularly when standing up quickly from a lying or sitting position. To minimize this risk, stand up slowly.
To maximize the benefits of CTD-O 6.25/40 Tablet and maintain your health, adopt a healthy lifestyle. This includes a balanced diet low in salt, regular exercise, and stress management techniques like yoga, meditation, or hobbies. Prioritize sufficient sleep nightly to help regulate blood pressure. Quit smoking and limit alcohol intake to lower blood pressure and protect your heart. A diet rich in whole grains, fruits, vegetables, and low-fat options is crucial. Consult your doctor for personalized guidance.
CTD-O 6.25/40 Tablet does not typically cause weight gain. While rare, significant weight loss due to chronic diarrhea is a possible side effect. If diarrhea develops during treatment and other causes are ruled out, your doctor might recommend stopping the medication and trying an alternative.
CTD-O 6.25/40 Tablet may cause serious side effects such as skin rash or itching, joint pain, rapid heartbeat, shortness of breath or chest tightness, muscle aches, tenderness, or weakness (unrelated to exercise), and swelling in the hands, feet, or ankles. High potassium levels, indicated by nausea, diarrhea, muscle weakness, and irregular heartbeat, are also possible. Seek immediate medical attention if you experience any of these symptoms.
Certain blood pressure medications, such as diuretics like hydrochlorothiazide, might impair erectile function. Conversely, other blood pressure drugs may actually improve it. Discuss any concerns or changes with your doctor. Currently, there's no conclusive evidence linking CTD-O 6.25/40 Tablet use to fertility issues in men or women.
Lifelong treatment with CTD-O 6.25/40 Tablet may be necessary to manage, not cure, high blood pressure. Continue taking it even with controlled blood pressure. While generally safe for long-term use, kidney function may be affected in some cases. Regular blood tests (urea, creatinine, and potassium) will monitor kidney health.
Discontinue CTD-O 6.25/40 Tablet 24 hours prior to surgery as advised by your doctor. This medication can lower blood pressure, potentially interacting negatively with anesthetics. Therefore, always inform your doctor if you are taking CTD-O 6.25/40 Tablet before undergoing surgery or receiving general anesthesia.
CTD-O 6.25/40 Tablet
216
MRP 263
17% off